Because of PSM, there were no statistically significant differences in these characteristics, namely age, income level, urbanization, menopausal status, HER2 status, AJCC clinical stage, CCI score, type of breast surgery, and the presence of diabetes, hyperlipidemia, ESRD, liver cirrhosis, AMI, CAD, stroke, hormone receptors, differentiation of tumor, nodal surgery, chemotherapy, and adjuvant RT. This evidence concerns the gene NR4A1 and neoplasm.